Miscellaneous and General

I147 Index.

The expressions listed in the left-hand column below are respectively defined or (as the case may be) are to be interpreted in accordance with the provisions of this Act listed in the right-hand column in relation to those expressions.

Activities governed by this Act

Section 4(5)

F22Appeals committee

F22Section 20A(2)

Authority

Section 2(1)

F1Basic partner treatment services

Section 2(1)

Carry, in relation to a child

Section 2(3)

F25. . .

F25. . .

Directions

Section 2(1)

F2Distribution, in relation to gametes or embryos intended for human application

Section 2(1)

Embryo F19(except in section 4A or in the term “human admixed embryo”)

Section 1

F3First Directive

Section 1A

F24Fourth Directive

Section 1A

Gametes, eggs or sperm F20(except in section 4A)

Section 1

F22Human admixed embryo

F22Section 4A(6)

F4Human application

Section 2(1)

F24Importing licensee

Section 2B(2

Keeping, in relation to embryos or gametes

Section 2(2)

Licence

Section 2(1)

F23. . .

F23. . .

F23. . .

F23. . .

F5Non-medical fertility services

Section 2(1)

F22Nuclear DNA (in relation to an embryo)

F22Section 2(1)

F6Partner-donated sperm

Section 1(5)

Person responsible

Section 17(1)

Person to whom a licence applies

Section 17(2)

F7Person to whom a third party agreement applies

Section 2A(3)

F8Processing, in relation to gametes or embryos intended for human application

Section 2(1)

F9Procurement, in relation to gametes or embryos intended for human application

Section 2(1)

F24Qualifying gametes or embryos

Section 2B(3)

F10Relevant third party premises, in relation to a licence

Section 2A(2)

F11Second Directive

Section 1A

F12Serious adverse event

Section 2(1)

F13Serious adverse reaction

Section 2(1)

F27. . .

F27. . .

Store, and similar expressions, in relation to embryosF21, human admixed embryos or gametes

F14Section 2(1)

F24Third country

Section 2B(4)

F24Third country premises

Section 2B(5)

F24Third country supplier

Section 2B(6)

F15Third Directive

Section 1A

F16Third party

Section 2A(2)

F17Third party agreement

Section 2A(1)

F26Tissue establishment

Section 2(1)

F18Traceability

Section 2(1)

Treatment services

Section 2(1)